Shares of Jazz Pharmaceuticals JAZZ are higher on the session by 3.34%, currently trading at $19.63. The stock has been moving largely higher over the past six months and is currently trading above the 50-day and 200-day moving averages.
Options traders are buying calls on the name today. Though action has been primarily in small lots, overall call volume is now running at 3.06x the daily average with 93% of all calls traded being purchases on the offer.
Traders are buying the $19.00 and $20.00 strike in January 2011.
Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focusing on the development and commercialization of pharmaceutical products to meet unmet medical needs in neurology and psychiatry.
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in